🌱 KidneyEnergy.com

← brief for 2026-08-19 · Slowing decline

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

Trial B Not peer reviewed Small trial

Key takeaways

This trial will test if SGLT2 inhibitors are safe to use in children with kidney disease. It is a feasibility study for 40 patients over 3 months.

Who did this work

Run by Ann & Robert H Lurie Children's Hospital of Chicago.
Sites: Ann & Robert H. Lurie Children's Hospital of Chicago

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-08-19
https://clinicaltrials.gov/study/NCT06430684